Related Experiment Video

Updated: May 19, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Cytomegalovirus infection in brain tumors: A potential new target for therapy?

Cecilia Söderberg-Nauclér1, John Inge Johnsen

  • 1Department of Medicine, Solna; Center for Molecular Medicine and Childhood; Stockholm, Sweden.

Oncoimmunology
|August 31, 2012
PubMed

Insights

Cytomegalovirus (CMV) is frequently found in tumors, suggesting it plays a role in cancer development. Targeting CMV may offer a new approach for effective cancer treatment.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Emerging evidence indicates a significant presence of cytomegalovirus (CMV) proteins and nucleic acids within various human tumors.
  • CMV is specifically detected within tumor cells, with adjacent non-cancerous cells consistently testing negative for the virus.

Purpose of the Study:

  • To investigate the prevalence and role of cytomegalovirus (CMV) in different types of cancer.
  • To explore the potential of CMV as a novel therapeutic target in cancer treatment.

Main Methods:

  • Detection of CMV proteins and nucleic acids in tumor tissues.
  • Analysis of CMV localization within tumor microenvironments.
  • Evaluation of CMV's oncogenic and oncomodulatory mechanisms.

Main Results:

  • High prevalence of CMV genetic material and proteins observed across diverse tumor types.
  • CMV was exclusively localized to tumor cells, sparing surrounding healthy tissues.
  • Evidence suggests CMV possesses both oncogenic and oncomodulatory functions.

Conclusions:

  • Cytomegalovirus (CMV) is frequently associated with human cancers.
  • CMV's dual role in promoting and modulating cancer suggests its potential as a novel therapeutic target.
  • Targeting CMV could represent a promising new strategy in oncological treatment paradigms.

More Related Videos

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...